EYES Annual Working Capital
$68.05 M
+$68.91 M+7984.70%
31 December 2021
Summary:
As of February 1, 2025, EYES annual working capital is $68.05 million, with the most recent change of +$68.91 million (+7984.70%) on December 31, 2021. During the last 3 years, it has risen by +$66.02 million (+3265.23%).EYES Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EYES Quarterly Working Capital
$54.80 M
-$3.03 M-5.25%
30 June 2022
Summary:
As of February 1, 2025, EYES quarterly working capital is $54.80 million, with the most recent change of -$3.03 million (-5.25%) on June 30, 2022. Over the past year, it has dropped by -$16.98 million (-23.66%).EYES Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EYES Working Capital Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +7984.7% | -23.7% |
3 y3 years | +3265.2% | +171.2% |
5 y5 years | +938.9% | +215.9% |
EYES Working Capital High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | ||||
5 y | 5-year | ||||
alltime | all time | at high | -23.7% |
Second Sight Medical Products Working Capital History
Date | Annual | Quarterly |
---|---|---|
June 2022 | - | $54.80 M(-5.2%) |
Mar 2022 | - | $57.83 M(-15.0%) |
Dec 2021 | $68.05 M(-7984.7%) | $68.05 M(-1.8%) |
Sept 2021 | - | $69.30 M(-3.4%) |
June 2021 | - | $71.78 M(+247.1%) |
Mar 2021 | - | $20.68 M(-2496.4%) |
Dec 2020 | -$863.00 K(-114.0%) | -$863.00 K(-362.3%) |
Sept 2020 | - | $329.00 K(-82.3%) |
June 2020 | - | $1.86 M(-219.4%) |
Mar 2020 | - | -$1.56 M(-125.3%) |
Dec 2019 | $6.15 M(+204.2%) | $6.15 M(-53.3%) |
Sept 2019 | - | $13.17 M(-34.8%) |
June 2019 | - | $20.21 M(-26.8%) |
Mar 2019 | - | $27.60 M(+1265.1%) |
Dec 2018 | $2.02 M(-69.1%) | $2.02 M(-26.4%) |
Sept 2018 | - | $2.75 M(-48.0%) |
June 2018 | - | $5.29 M(+136.7%) |
Mar 2018 | - | $2.23 M(-65.9%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2017 | $6.55 M(-31.9%) | $6.55 M(-43.6%) |
Sept 2017 | - | $11.61 M(-33.1%) |
June 2017 | - | $17.34 M(-24.1%) |
Mar 2017 | - | $22.85 M(+137.6%) |
Dec 2016 | $9.62 M(-48.8%) | $9.62 M(-49.4%) |
Sept 2016 | - | $19.02 M(-28.3%) |
June 2016 | - | $26.51 M(+83.4%) |
Mar 2016 | - | $14.46 M(-23.0%) |
Dec 2015 | $18.78 M(-44.0%) | $18.78 M(-18.6%) |
Sept 2015 | - | $23.08 M(-14.2%) |
June 2015 | - | $26.91 M(-8.5%) |
Mar 2015 | - | $29.40 M(-12.3%) |
Dec 2014 | $33.52 M(+268.2%) | $33.52 M(+663.9%) |
Sept 2014 | - | $4.39 M(-42.9%) |
June 2014 | - | $7.68 M(+30.6%) |
Mar 2014 | - | $5.88 M(-35.4%) |
Dec 2013 | $9.10 M(+112.9%) | $9.10 M |
Dec 2012 | $4.28 M | - |
FAQ
- What is Second Sight Medical Products annual working capital?
- What is the all time high annual working capital for Second Sight Medical Products?
- What is Second Sight Medical Products annual working capital year-on-year change?
- What is Second Sight Medical Products quarterly working capital?
- What is the all time high quarterly working capital for Second Sight Medical Products?
- What is Second Sight Medical Products quarterly working capital year-on-year change?
What is Second Sight Medical Products annual working capital?
The current annual working capital of EYES is $68.05 M
What is the all time high annual working capital for Second Sight Medical Products?
Second Sight Medical Products all-time high annual working capital is $68.05 M
What is Second Sight Medical Products annual working capital year-on-year change?
Over the past year, EYES annual working capital has changed by +$68.91 M (+7984.70%)
What is Second Sight Medical Products quarterly working capital?
The current quarterly working capital of EYES is $54.80 M
What is the all time high quarterly working capital for Second Sight Medical Products?
Second Sight Medical Products all-time high quarterly working capital is $71.78 M
What is Second Sight Medical Products quarterly working capital year-on-year change?
Over the past year, EYES quarterly working capital has changed by -$16.98 M (-23.66%)